News | September 10, 2008

LUMEDX Receives ACC-NCDR CARE Registry Vendor Certification

September 11, 2008 - The American College of Cardiology (ACC) has certified LUMEDX an ACC-NCDR CARE Registry software vendor, making LUMEDX the first vendor certified for carotid stent procedures.

LUMEDX's Export to CARE Registry solution is the latest in a suite of software applications developed to address the growing need for impeccable, accessible vascular data, streamlined clinical workflows and superior data management.

The new ACC-NCDR CARE Registry collects data for carotid artery revascularization and endarterectomy procedures, and meets Center for Medicare and Medicaid Services (CMS) data collection requirements for carotid stenting.

LUMEDX's Export to CARE Registry software enables simple, straightforward data capture and submission by helping hospitals automate the processes. LUMEDX software enables hospitals to:

- Capture data at the point of care
- Submit automatically to the ACC
- Track additional data elements
- Run reports internally
- Review program performance
- Take an active role in improving outcomes

The Export to CARE Registry is part of the Apollo Advance Peripheral Vascular Invasive (PVI) Module, enabling clinics to extend their scope and collect additional data for years of patient follow-up, internal benchmarking, outcomes improvement and clinical research.

For more information:

Related Content

Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot. Catheter directed thrombolysis of deep vein thrombosis.

Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot.

Feature | Deep Vein Thrombosis (DVT) | February 16, 2018 | Sanjay Pandya, M.D.
There are few downsides to using tibial venous access to treat...
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis (DVT) | July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
NICE, U.K., edoxaban, Lixiana, VTE, venous thromboembolism, deep vein thrombosis, pulmonary embolism
News | Deep Vein Thrombosis (DVT) | August 12, 2015
The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients suffering...
Overlay Init